$58.38
1.031.80%
At close: -
$58.38
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Bio-Techne Insider Trading Activity | NASDAQ:TECH | Benzinga
Track the latest Bio-Techne insider trading activity. Stay informed on recent buys, sells, and market impact for Bio-Techne stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Bio-Techne Corp Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Bio-Techne Corp
Shares Outstanding
158.088M
Insider Shares Owned
2.946M
Insider Percentage Owned
1.86%
Institutional Shares Held
126.691M
Institutional Percentage Held
80.1%
| Feb 18, 2025 | Amy E Herr | DIRECTOR | 116.00 | $55.15 | -$35.09K | SELL-OPTIONS | 4.00% | 3.02K | Feb 14 | View |
| Jan 29, 2025 | Kim Kelderman | CHIEF EXECUTIVE OFFICER | 0.00 | $57.49 | -$530.14K | SELL-OPTIONS | 0.00% | 39.00K | Jan 27 | View |
| Aug 12, 2024 | Robert V Baumgartner | DIRECTOR | 0.00 | $47.53 | -$786.46K | SELL-OPTIONS | 0.00% | 43.40K | Aug 08 | View |
| May 16, 2024 | John L Higgins | DIRECTOR | 0.00 | $53.40 | -$243.58K | SELL-OPTIONS | 0.00% | 36.61K | May 14 | View |
| Mar 11, 2024 | Roeland Nusse | DIRECTOR | -10.40K | $76.98 | -$800.63K | SELL | -19.44% | 43.10K | Mar 07 | View |
| Sep 01, 2023 | Roeland Nusse | DIRECTOR | 23.06K | $51.36 | -$1.16K | SELL-OPTIONS | 80.04% | 51.87K | Aug 30 | View |
| Jul 25, 2023 | Charles Kummeth | CHIEF EXECUTIVE OFFICER | -80.00K | $88.36 | -$7.07M | SELL | -5.97% | 1.26M | Jul 21 | View |
| Jun 09, 2023 | Charles Kummeth | CHIEF EXECUTIVE OFFICER | -322.00 | $83.00 | -$26.73K | SELL | -0.03% | 1.11M | Jun 07 | View |
| Dec 09, 2022 | Brenda S Furlow | SVP - GENERAL COUNSEL | 0.00 | $56.69 | -$419.50K | SELL-OPTIONS | 0.00% | 31.41K | Dec 07 - Dec 08 | View |
| Aug 12, 2022 | JOHN HIGGINS | DIRECTOR | 896.00 | $222.85 | -$721.06K | SELL-OPTIONS | 19.45% | 5.50K | Aug 10 - Aug 11 | View |
| Jun 09, 2022 | JOHN HIGGINS | — | 0.00 | $215.94 | -$476.92K | SELL-OPTIONS | 0.00% | 4.61K | Jun 07 - Jun 08 | View |
| Jun 09, 2022 | Charles Kummeth | CHIEF EXECUTIVE OFFICER | 0.00 | $236.75 | -$1.31M | SELL-OPTIONS | 0.00% | 198.44K | Jun 07 | View |
| May 11, 2022 | Robert V Baumgartner | — | 300.00 | $352.55 | $105.77K | BUY | 3.06% | 10.11K | May 10 | View |
| Nov 23, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | 0.00 | $328.08 | -$177.30K | SELL-OPTIONS | 0.00% | 0.00 | Nov 19 | View |
| Nov 16, 2021 | N. David Eansor pursuant to Power of Attorney previously filed. | PRESIDENT-PROTEIN SCIENCES | 799.00 | $314.53 | -$10.19M | SELL-OPTIONS | 60.62% | 2.12K | Nov 12 - Nov 16 | View |
| Nov 03, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0.00 | $325.77 | -$3.62M | SELL-OPTIONS | 0.00% | 10.76K | Nov 01 - Nov 02 | View |
| Nov 01, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | -100.00 | $325.14 | -$317.44K | SELL | -0.92% | 10.76K | Oct 28 - Oct 29 | View |
| Sep 24, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | -822.00 | $529.04 | -$434.87K | SELL | -100.00% | 0.00 | Sep 22 | View |
| Sep 09, 2021 | Randolph C Steer | DIRECTOR | 0.00 | $299.78 | -$3.36M | SELL-OPTIONS | 0.00% | 5.11K | Sep 07 | View |
| Sep 07, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0.00 | $306.90 | -$4.01M | SELL-OPTIONS | 0.00% | 10.86K | Sep 02 | View |
| Sep 07, 2021 | Brenda S Furlow | SVP - GENERAL COUNSEL | 0.00 | $317.49 | -$2.64M | SELL-OPTIONS | 0.00% | 7.62K | Sep 02 | View |
| Sep 02, 2021 | N. David Eansor pursuant to Power of Attorney previously filed. | PRESIDENT-PROTEIN SCIENCES | -1.54K | $503.07 | -$773.73K | SELL | -53.85% | 1.32K | Aug 31 | View |
| Sep 02, 2021 | Brenda S Furlow | SVP - GENERAL COUNSEL | 0.00 | $315.36 | -$1.90M | SELL-OPTIONS | 0.00% | 7.62K | Aug 31 | View |
| Aug 25, 2021 | Roeland Nusse | DIRECTOR | 0.00 | $275.93 | -$1.64M | SELL-OPTIONS | 0.00% | 6.76K | Aug 23 | View |
| Aug 25, 2021 | Robert V Baumgartner | DIRECTOR | 0.00 | $286.47 | -$1.59M | SELL-OPTIONS | 0.00% | 9.61K | Aug 23 | View |
| Aug 23, 2021 | Brenda S Furlow | SVP - GENERAL COUNSEL | 799.00 | $291.97 | -$1.20M | SELL-OPTIONS | 11.71% | 7.62K | Aug 19 | View |
| Aug 10, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 1.72K | $292.95 | -$4.53M | SELL-OPTIONS | 18.80% | 10.86K | Aug 08 - Aug 09 | View |
| Jul 14, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0.00 | $281.63 | -$3.50M | SELL-OPTIONS | 0.00% | 9.14K | Jul 12 | View |
| Jun 21, 2021 | Charles R Kummeth | CHIEF EXECUTIVE OFFICER | -12.50K | $449.67 | -$5.62M | SELL | -7.48% | 154.51K | Jun 17 - Jun 18 | View |
| Jun 16, 2021 | Charles R Kummeth | CHIEF EXECUTIVE OFFICER | -7.48K | $449.15 | -$3.36M | SELL | -4.29% | 167.00K | Jun 14 | View |
| Jun 11, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | -811.00 | $433.00 | -$351.16K | SELL | -100.00% | 0.00 | Jun 09 | View |
| Jun 09, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0.00 | $264.26 | -$3.14M | SELL-OPTIONS | 0.00% | 9.14K | Jun 07 | View |
| May 27, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | -845.00 | $424.00 | -$358.28K | SELL | -51.03% | 811.00 | May 25 | View |
| Feb 17, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0.00 | $253.49 | -$2.94M | SELL-OPTIONS | 0.00% | 9.14K | Feb 12 | View |
| Feb 17, 2021 | Brenda S Furlow | SVP - GENERAL COUNSEL | 0.00 | $252.61 | -$2.92M | SELL-OPTIONS | 0.00% | 6.12K | Feb 12 | View |
| Feb 10, 2021 | Roeland Nusse | DIRECTOR | 0.00 | $226.28 | -$1.91M | SELL-OPTIONS | 0.00% | 6.76K | Feb 08 | View |
| Feb 09, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | -823.00 | $388.45 | -$319.69K | SELL | -49.34% | 845.00 | Feb 05 | View |
| Feb 09, 2021 | N. David Eansor pursuant to Power of Attorney previously filed. | PRESIDENT-PROTEIN SCIENCES | 0.00 | $243.64 | -$9.03M | SELL-OPTIONS | 0.00% | 1.32K | Feb 05 | View |
| Jan 20, 2021 | Charles R Kummeth | CHIEF EXECUTIVE OFFICER | -20.00K | $344.00 | -$6.88M | SELL | -12.02% | 146.37K | Jan 15 | View |
| Jan 13, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0.00 | $220.11 | -$2.27M | SELL-OPTIONS | 0.00% | 9.14K | Jan 11 | View |
| Dec 09, 2020 | Charles R Kummeth | — | -5.00K | $308.00 | -$1.54M | SELL | -2.92% | 166.37K | Dec 07 | View |
| Dec 02, 2020 | Brenda S Furlow | — | 938.00 | $204.26 | -$2.02M | OPTION EXERCISE | 18.09% | 6.12K | Nov 30 | View |
| Nov 20, 2020 | Robert V Baumgartner | — | 0.00 | $185.12 | -$1.18M | OPTION EXERCISE | 0.00% | 9.61K | Nov 18 | View |
| Nov 19, 2020 | Seth Alpna | — | 0.00 | $226.19 | -$808.05K | OPTION EXERCISE | 0.00% | 2.14K | Nov 09 | View |
| Nov 12, 2020 | James Hippel | — | 0.00 | $207.27 | -$2.21M | OPTION EXERCISE | 0.00% | 9.14K | Nov 09 - Nov 11 | View |
| Nov 10, 2020 | Randolph C Steer | — | 0.00 | $185.31 | -$2.33M | OPTION EXERCISE | 0.00% | 5.11K | Nov 06 | View |
| Nov 10, 2020 | John L Higgins | — | 0.00 | $185.35 | -$1.15M | OPTION EXERCISE | 0.00% | 4.41K | Nov 06 | View |
| Nov 06, 2020 | James Hippel | — | 0.00 | $194.60 | -$2.74M | OPTION EXERCISE | 0.00% | 9.14K | Nov 04 - Nov 05 | View |
| Jul 13, 2020 | Brenda S Furlow | — | 0.00 | $192.13 | -$1.52M | OPTION EXERCISE | 0.00% | 4.31K | Jul 09 | View |
| Jul 08, 2020 | James Hippel | — | 0.00 | $190.04 | -$3.93M | OPTION EXERCISE | 0.00% | 9.31K | Jul 06 - Jul 07 | View |
| Jun 02, 2020 | Harold J Wiens | — | -378.00 | $180.59 | -$632.86K | GIFT | -7.24% | 4.84K | May 22 - May 29 | View |
| Jun 01, 2020 | Brenda S Furlow | — | 1.60K | $182.83 | -$758.18K | OPTION EXERCISE | 59.02% | 4.31K | May 28 | View |
| Jun 01, 2020 | N. David Eansor pursuant to Power of Attorney previously filed. | — | 0.00 | $184.97 | -$1.74M | OPTION EXERCISE | 0.00% | 0.00 | May 28 - May 29 | View |
| May 26, 2020 | N. David Eansor pursuant to Power of Attorney previously filed. | — | 0.00 | $183.62 | -$3.98M | OPTION EXERCISE | 0.00% | 0.00 | May 21 - May 22 | View |
| May 26, 2020 | Robert V Baumgartner | — | 0.00 | $168.39 | -$980.37K | OPTION EXERCISE | 0.00% | 9.22K | May 21 | View |
| May 08, 2020 | Harold J Wiens | — | 0.00 | $168.67 | -$692.93K | OPTION EXERCISE | 0.00% | 5.22K | May 06 | View |
| May 04, 2020 | Harold J Wiens | — | 0.00 | $158.39 | -$532.88K | OPTION EXERCISE | 0.00% | 5.22K | Apr 30 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.